[Federal Register Volume 68, Number 112 (Wednesday, June 11, 2003)]
[Notices]
[Page 35006]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-14735]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 24, 2002, Noramco, 
Inc. (formerly Noramco of Delaware, Inc.), 500 Swedes Landing Road, 
Wilmington, Delaware 19801, made application by renewal and on December 
4 and 26, 2002, by letters to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Morphine-N-Oxide...........................  I
Codeine-N-Oxide (9053).....................  I
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers as bulk products.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than August 
11, 2003.

    Dated: May 16, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-14735 Filed 6-10-03; 8:45 am]
BILLING CODE 4410-09-M